Our study further demonstrated that TMZ has a potential anti-rheumatoid activity, similar to that of the well-known MTX drug, by targeting the miRNA 128a, TLR4/MYD88, IKB/NF-κB, and adenosine pathways in the RA model. The gene discussed is MYD88; the disease is rheumatoid arthritis.